Location History:
- Jiangsu, CN (2022)
- Suzhou, CN (2023)
Company Filing History:
3 out of 7 
1 out of 8 Years Active: 2022-2025
Title: Pilin Wang: Innovator in Tumor Treatment
Introduction
Pilin Wang is a prominent inventor based in Jiangsu, China, known for his significant contributions to the field of biopharmaceuticals. He holds a total of 4 patents, showcasing his innovative approach to cancer treatment.
Latest Patents
Wang's latest patents include a groundbreaking method for treating tumors using anti-CTLA4 single-domain antibodies. This method involves a CTLA4-binding protein that specifically binds to CTLA4 without competing with its ligand, effectively inhibiting tumor growth. Another notable patent is for a dimer formed by two polypeptide chains, each comprising an antibody Fc subunit. This dimer includes two or more immunoglobulin single variable domains (ISVDs), with at least one ISVD specific for PD-L1 and another for CTLA4.
Career Highlights
Throughout his career, Pilin Wang has worked with notable companies such as Jiangsu Alphamab Biopharmaceuticals Co., Ltd. and Suzhou Alphamab Co., Ltd. His work has significantly advanced the understanding and treatment of tumors, positioning him as a key figure in the biopharmaceutical industry.
Collaborations
Wang has collaborated with esteemed colleagues, including Ting Xu and Yuhao Jin, further enhancing his research and development efforts in the field.
Conclusion
Pilin Wang's innovative work in tumor treatment through his patented methods demonstrates his commitment to advancing medical science. His contributions continue to impact the biopharmaceutical landscape positively.